Founded in 2013, Rincon Bio is a pre-clinical CRO focusing on in vivo cancer efficacy studies, both allogeneic (human cell models) and syngeneic (immunotherapy models). We deliver:

—DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

—SPEED TO INITIATION
Most efficacy studies can be initiated within two business days.

—PERSONAL TOUCH
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients’ studies.

The staff at Rincon Bio have performed hundreds of efficacy studies for pharmaceutical researchers across the United States and Europe, both in industry and in academia. We’ve worked in the world of small, agile, start-up pharma, which gives us a unique perspective as a CRO. We appreciate that your priorities change quickly, and you need a partner that can adapt along with you. Furthermore, we can initiate most efficacy studies more quickly than any other CRO.

We understand the importance of transparency and communication: at Rincon Bio, our clients are assigned a single point-of-contact, who is responsible for managing their study from conception to completion.

Rincon Bio is a US-based organization, born from a desire to simplify the process of running cancer efficacy studies, and to provide domestic quality at competitive prices. We are The Cancer Model CRO – we believe in doing one thing, and doing it well.

If you do decide to run your study at Rincon Bio, the process will be easy, streamlined, and pleasant.